FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Thomas Stamey

Research Profile

Disorders

Chemicals & Drugs

Procedures

Anatomy

Concepts & Ideas

Co-author Network

Publications

TOP 3
Susan Cottrell; Klaus Jung; Glen Kristiansen; Elke Eltze; Axel Semjonow; Michael Ittmann; Arndt Hartmann; Thomas A Stamey; Carolina Haefliger; Gunter Weiss
Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis.
Amy Rose; Yue Xu; Zuxiong Chen; Zengbin Fan; Thomas A Stamey; John E McNeal; Mitchell Caldwell; Donna M Peehl
Comparative gene and protein expression in primary cultures of epithelial cells from benign prostatic hyperplasia and prostate cancer.
Thomas A Stamey
The era of serum prostate specific antigen as a marker for biopsy of the prostate and detecting prostate cancer is now over in the USA.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Thomas Stamey (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Susan Cottrell; Klaus Jung; Glen Kristiansen; Elke Eltze; Axel Semjonow; Michael Ittmann; Arndt Hartmann; Thomas A Stamey; Carolina Haefliger; Gunter Weiss
Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis.
The Journal of urology 2007;177(5):1753-8.
2005: Amy Rose; Yue Xu; Zuxiong Chen; Zengbin Fan; Thomas A Stamey; John E McNeal; Mitchell Caldwell; Donna M Peehl
Comparative gene and protein expression in primary cultures of epithelial cells from benign prostatic hyperplasia and prostate cancer.
Cancer letters 2005;227(2):213-22.
2004: Thomas A Stamey
The era of serum prostate specific antigen as a marker for biopsy of the prostate and detecting prostate cancer is now over in the USA.
BJU international 2004;94(7):963-4.
2004: Thomas A Stamey; Mitchell Caldwell; John E McNeal; Rosalie Nolley; Marci Hemenez; Joshua Downs
The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?
The Journal of urology 2004;172(4 Pt 1):1297-301.
2004: Ian Krop; Audrey Player; Ana Tablante; Michele Taylor-Parker; Jaana Lahti-Domenici; Junya Fukuoka; Surinder Batra; Nickolas Papadopoulos; William G Richards; David J Sugarbaker; Renée L Wright; Judy Shim; Thomas A Stamey; William R Sellers; Massimo Loda; Matthew Meyerson; Ralph Hruban; Jin Jen; Kornelia Polyak
Frequent HIN-1 promoter methylation and lack of expression in multiple human tumor types.
Molecular cancer research : MCR 2004;2(9):489-94.
2004: Gail P Risbridger; A Shibata; K L Ferguson; Thomas A Stamey; J E McNeal; D M Peehl
Elevated expression of inhibin alpha in prostate cancer.
The Journal of urology 2004;171(1):192-6.
2003: Yoshio Naya; Herbert A Fritsche; Carol D Cheli; Thomas A Stamey; Georg Bartsch; Michael K Brawer; Stacy Childs; Samir S Taneja; Herbert Lepor; Alan W Partin; Lori J Sokoll; Daniel W Chan; R Joseph Babaian
Volume indexes of total, free, and complexed prostate-specific antigen enhance prediction of extraprostatic disease extension in men with nonpalpable prostate cancer.
Urology 2003;62(6):1058-62.
2003: Thomas A Stamey; Mitchell C Caldwell; Zhenbin Fan; Zhaomei Zhang; John E McNeal; Rosalie Nolley; Zuxiong Chen; Mamatha Mahadevappa; Janet A Warrington
Genetic profiling of Gleason grade 4/5 prostate cancer: which is the best prostatic control tissue?
The Journal of urology 2003;170(6 Pt 1):2263-8.
2003: Alan W Partin; Michael K Brawer; Georg Bartsch; Wolfgang Horninger; Samir S Taneja; Herbert Lepor; R Joseph Babaian; Stacy J Childs; Thomas A Stamey; Herbert A Fritsche; Lori J Sokoll; Daniel W Chan; Robert P Thiel; Carol D Cheli
Complexed prostate specific antigen improves specificity for prostate cancer detection: results of a prospective multicenter clinical trial.
The Journal of urology 2003;170(5):1787-91.
2003: Masanori Noguchi; Thomas A Stamey; John E McNeal; Rosalie Nolley
Prognostic factors for multifocal prostate cancer in radical prostatectomy specimens: lack of significance of secondary cancers.
The Journal of urology 2003;170(2 Pt 1):459-63.
2003: Thomas A Stamey
More information on prostate specific antigen and prostate cancer.
The Journal of urology 2003;170(2 Pt 1):457-8.
2003: Zuxiong Chen; Zhenbin Fan; John E McNeal; Rosalie Nolley; Mitchell C Caldwell; Mamatha Mahadevappa; Zhaomei Zhang; Janet A Warrington; Thomas A Stamey
Hepsin and maspin are inversely expressed in laser capture microdissectioned prostate cancer.
The Journal of urology 2003;169(4):1316-9.
2003: Yue Xu; Atsuko Shibata; John E McNeal; Thomas A Stamey; David Feldman; Donna M Peehl
Vitamin D receptor start codon polymorphism (FokI) and prostate cancer progression.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(1):23-7.
2002: Yoshio Naya; Thomas A Stamey; Carol D Cheli; Alan W Partin; Lori J Sokoll; Daniel W Chan; Michael K Brawer; Samir S Taneja; Herbert Lepor; Georg Bartsch; Stacy Childs; Herbert A Fritsche; R Joseph Babaian
Can volume measurement of the prostate enhance the performance of complexed prostate-specific antigen?
Urology 2002;60(4 Suppl 1):36-41.
2002: Wolfgang Horninger; Carol D Cheli; R Joseph Babaian; Herbert A Fritsche; Herbert Lepor; Samir S Taneja; Stacy Childs; Thomas A Stamey; Lori J Sokoll; Daniel W Chan; Michael K Brawer; Alan W Partin; Georg Bartsch
Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliter.
Urology 2002;60(4 Suppl 1):31-5.
2002: Samir S Taneja; Elias I Hsu; Carol D Cheli; Paul D Walden; Georg Bartsch; Wolfgang Horninger; R Joseph Babaian; Herbert A Fritsche; Stacy Childs; Thomas A Stamey; Lori J Sokoll; Daniel W Chan; Michael K Brawer; Alan W Partin; Herbert Lepor
Complexed prostate-specific antigen as a staging tool: results based on a multicenter prospective evaluation of complexed prostate-specific antigen in cancer diagnosis.
Urology 2002;60(4 Suppl 1):10-7.
2002: Atsuko Shibata; Maria Isabel Garcia; Iona Cheng; Thomas A Stamey; John E McNeal; James D Brooks; Stavonnie Henderson; Cheryl E Yemoto; Donna M Peehl
Polymorphisms in the androgen receptor and type II 5 alpha-reductase genes and prostate cancer prognosis.
The Prostate 2002;52(4):269-78.
2002: Alphaeus M Wise; Thomas A Stamey; John E McNeal; John L Clayton
Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens.
Urology 2002;60(2):264-9.
2002: Thomas A Stamey
Re: Pathologic features of prostate cancer found at population-based screening with a four-year interval.
Journal of the National Cancer Institute 2002;94(3):227-9.
2002: Thomas A Stamey; Iain M Johnstone; John E McNeal; Arthur Y Lu; Cheryl M Yemoto
Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml.
The Journal of urology 2002;167(1):103-11.
2001: Thomas A Stamey; Janet A Warrington; Mitchell C Caldwell; Zuxiong Chen; Zhenbin Fan; Mamatha Mahadevappa; John E McNeal; Rosalie Nolley; Zhaomei Zhang
Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia.
The Journal of urology 2001;166(6):2171-7.
2001: Atsuko Shibata; Thomas A Stamey; John E McNeal; I Cheng; Donna M Peehl
Genetic polymorphisms in the androgen receptor and type II 5 alpha-reductase genes in prostate enlargement.
The Journal of urology 2001;166(4):1560-4.
2001: M Noguchi; Thomas A Stamey; John E McNeal; Cheryl M Yemoto
Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer.
The Journal of urology 2001;166(1):104-9; discussion 109-10.
2000: M Noguchi; Thomas A Stamey; John E McNeal; Cheryl M Yemoto
Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers.
The Journal of urology 2000;164(5):1596-600.
2000: M Noguchi; Thomas A Stamey; John E McNeal; Cheryl E Yemoto
Assessment of morphometric measurements of prostate carcinoma volume.
Cancer 2000;89(5):1056-64.
2000: M Noguchi; Thomas A Stamey; J E Neal; Cheryl E Yemoto
An analysis of 148 consecutive transition zone cancers: clinical and histological characteristics.
The Journal of urology 2000;163(6):1751-5.
2000: Thomas A Stamey; Cheryl M Yemoto; John E McNeal; Bronislava M Sigal; Iain M Johnstone
Prostate cancer is highly predictable: a prognostic equation based on all morphological variables in radical prostatectomy specimens.
The Journal of urology 2000;163(4):1155-60.
2000: Thomas A Stamey; Cheryl E Yemoto
Examination of the 3 molecular forms of serum prostate specific antigen for distinguishing negative from positive biopsy: relationship to transition zone volume.
The Journal of urology 2000;163(1):119-26.
1999: Larry F Chu; Zuxiong Chen; Thomas A Stamey
Different molecular forms of uncomplexed prostate specific antigen (PSA) show similar immunoreactivities.
The Journal of urology 1999;161(6):2009-12.
1999: Thomas A Stamey; John E McNeal; Cheryl M Yemoto; Bronislava M Sigal; Iain M Johnstone
Biological determinants of cancer progression in men with prostate cancer.
JAMA : the journal of the American Medical Association 1999;281(15):1395-400.
1998: Thomas A Stamey; A N Donaldson; Cheryl E Yemoto; John E McNeal; S Sözen; H Gill
Histological and clinical findings in 896 consecutive prostates treated only with radical retropubic prostatectomy: epidemiologic significance of annual changes.
The Journal of urology 1998;160(6 Pt 2):2412-7.
1998: Zuxiong Chen; H Chen; Thomas A Stamey
Monoclonal antibodies 2F5 and 4G10 against prostate specific antigen (PSA) complexed to alpha1-antichymotrypsin.
The Journal of urology 1998;160(3 Pt 1):870-5.
1998: Thomas A Stamey; Z Chen; AF Prestigiacomo
Reference material for PSA: the IFCC standardization study. International Federation of Clinical Chemistry.
Clinical biochemistry 1998;31(6):475-81.
1998: C Gross; Thomas A Stamey; S Hancock; David Feldman
Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3 (calcitriol)
The Journal of urology 1998;159(6):2035-9; discussion 2039-40.
1998: Thomas A Stamey; T S Sözen; Cheryl M Yemoto; John E McNeal
Classification of localized untreated prostate cancer based on 791 men treated only with radical prostatectomy: common ground for therapeutic trials and TNM subgroups.
The Journal of urology 1998;159(6):2009-12.
1998: L W Chan; Thomas A Stamey
Calculating prostate cancer volume preoperatively: the D'Amico equation and some other observations.
The Journal of urology 1998;159(6):1998-2003.
1998: Martha Kennedy Terris; AF Prestigiacomo; Thomas A Stamey
Comparison of prostate size in university and Veterans Affairs Health Care System patients with negative prostate biopsies.
Urology 1998;51(3):412-4.
1997: Atsuko Shibata; Alice S Whittemore; K Imai; Laurence N Kolonel; Anna H Wu; Esther M John; Thomas A Stamey; Ralph S Paffenbarger
Serum levels of prostate-specific antigen among Japanese-American and native Japanese men.
Journal of the National Cancer Institute 1997;89(22):1716-20.
1997: J Noldus; Zuxiong Chen; Thomas A Stamey
Isolation and characterization of free form prostate specific antigen (f-PSA) in sera of men with prostate cancer.
The Journal of urology 1997;158(4):1606-9.
1997: Zuxiong Chen; H Chen; Thomas A Stamey
Prostate specific antigen in benign prostatic hyperplasia: purification and characterization.
The Journal of urology 1997;157(6):2166-70.
1997: Raj S Pruthi; Iain M Johnstone; I P Tu; Thomas A Stamey
Prostate-specific antigen doubling times in patients who have failed radical prostatectomy: correlation with histologic characteristics of the primary cancer.
Urology 1997;49(5):737-42.
1997: Raj S Pruthi; A Haese; Edith Huland; Thomas A Stamey
Use of serum concentration techniques to enhance early detection of recurrent prostate cancer after radical prostatectomy.
Urology 1997;49(3):404-10.
1997: Thomas A Stamey
Some comments on progress in the standardization of immunoassays for prostate-specific antigen.
British journal of urology 1997;79 Suppl 1():49-52.
1997: Martha Kennedy Terris; Eric Wallen; Thomas A Stamey
Comparison of mid-lobe versus lateral systematic sextant biopsies in the detection of prostate cancer.
Urologia internationalis 1997;59(4):239-42.
1997: AF Prestigiacomo; Thomas A Stamey
Can free and total prostate specific antigen and prostatic volume distinguish between men with negative and positive systematic ultrasound guided prostate biopsies?
The Journal of urology 1997;157(1):189-94.
1996: Zuxiong Chen; K Komatsu; A Prestigiacomo; Thomas A Stamey
Addition of purified prostate specific antigen to serum from female subjects: studies on the relative inhibition by alpha 2-macroglobulin and alpha 1-antichymotrypsin.
The Journal of urology 1996;156(4):1357-63.
1996: E S Geary; Thomas A Stamey
Pathological characteristics and prognosis of nonpalpable and palpable prostate cancers with a Hybritech prostate specific antigen of 4 to 10 ng./ml.
The Journal of urology 1996;156(3):1056-8.
1996: A F Prestigiacomo; Hans Lilja; K Pettersson; R L Wolfert; Thomas A Stamey
A comparison of the free fraction of serum prostate specific antigen in men with benign and cancerous prostates: the best case scenario.
The Journal of urology 1996;156(2 Pt 1):350-4.
1996: Thomas A Stamey
Lower limits of detection, biological detection limits, functional sensitivity, or residual cancer detection limit? Sensitivity reports on prostate-specific antigen assays mislead clinicians.
Clinical chemistry 1996;42(6 Pt 1):849-52.
1996: A F Prestigiacomo; Thomas A Stamey
Physiological variation of serum prostate specific antigen in the 4.0 to 10.0 ng./ml. range in male volunteers.
The Journal of urology 1996;155(6):1977-80.
1996: J Noldus; M Ferrari; A Prestigiacomo; Thomas A Stamey
Effect of flutamide and flutamide plus castration on prostate size in patients with previously untreated prostate cancer.
Urology 1996;47(5):713-8.
1996: K Komatsu; N Wehner; A F Prestigiacomo; Zuxiong Chen; Thomas A Stamey
Physiologic (intraindividual) variation of serum prostate-specific antigen in 814 men from a screening population.
Urology 1996;47(3):343-6.
1996: J Noldus; Thomas A Stamey
Histological characteristics of radical prostatectomy specimens in men with a serum prostate specific antigen of 4 ng./ml or less.
The Journal of urology 1996;155(2):441-3.
1996: J Noldus; Thomas A Stamey
Limitations of serum prostate specific antigen in predicting peripheral and transition zone cancer volumes as measured by correlation coefficients.
The Journal of urology 1996;155(1):232-7.
1995: Thomas A Stamey; David B Teplow; H C Graves
Identity of PSA purified from seminal fluid by different methods: comparison by amino acid analysis and assigned extinction coefficients.
The Prostate 1995;27(4):198-203.
1995: Alain Bélanger; H van Halbeek; H C Graves; K Grandbois; Thomas A Stamey; L Huang; I Poppe; Fernand Labrie
Molecular mass and carbohydrate structure of prostate specific antigen: studies for establishment of an international PSA standard.
The Prostate 1995;27(4):187-97.
1995: T Loch; John E McNeal; Thomas A Stamey
Interpretation of bilateral positive biopsies in prostate cancer.
The Journal of urology 1995;154(3):1078-83.
1995: Zuxiong Chen; A Prestigiacomo; Thomas A Stamey
Purification and characterization of prostate-specific antigen (PSA) complexed to alpha 1-antichymotrypsin: potential reference material for international standardization of PSA immunoassays.
Clinical chemistry 1995;41(9):1273-82.
1995: E S Geary; T E Dendinger; Fuad Freiha; Thomas A Stamey
Nerve sparing radical prostatectomy: a different view.
The Journal of urology 1995;154(1):145-9.
1995: J N Kabalin; J E McNeal; I M Johnstone; Thomas A Stamey
Serum prostate-specific antigen and the biologic progression of prostate cancer.
Urology 1995;46(1):65-70.
1995: D D Dietrick; J E McNeal; Thomas A Stamey
Core cancer length in ultrasound-guided systematic sextant biopsies: a preoperative evaluation of prostate cancer volume.
Urology 1995;45(6):987-92.
1995: E S Geary; T E Dendinger; Fuad Freiha; Thomas A Stamey
Incontinence and vesical neck strictures following radical retropubic prostatectomy.
Urology 1995;45(6):1000-6.
1995: P D Lui; Martha Kennedy Terris; John E McNeal; Thomas A Stamey
Indications for ultrasound guided transition zone biopsies in the detection of prostate cancer.
The Journal of urology 1995;153(3 Pt 2):1000-3.
1995: Thomas A Stamey
Second Stanford Conference on International Standardization of Prostate-Specific Antigen Immunoassays: September 1 and 2, 1994.
Urology 1995;45(2):173-84.
1995: Thomas A Stamey
Making the most out of six systematic sextant biopsies.
Urology 1995;45(1):2-12.
1995: A F Prestigiacomo; Zuxiong Chen; Thomas A Stamey
A universal calibrator for prostate specific antigen (PSA).
Scandinavian journal of clinical and laboratory investigation. Supplementum 1995;221():57-9.
1995: Martha Kennedy Terris; D J Haney; I M Johnstone; J E McNeal; Thomas A Stamey
Prediction of prostate cancer volume using prostate-specific antigen levels, transrectal ultrasound, and systematic sextant biopsies.
Urology 1995;45(1):75-80.
1995: P G Hammerer; John E McNeal; Thomas A Stamey
Correlation between serum prostate specific antigen levels and the volume of the individual glandular zones of the human prostate.
The Journal of urology 1995;153(1):111-4.
1994: H P Schmid; M K Ferrari; Thomas A Stamey
[Long-term follow-up of serum prostate-specific antigen after radiotherapy of prostatic carcinoma].
Helvetica chirurgica acta 1994;60(6):1101-5.
1994: A F Prestigiacomo; Thomas A Stamey
A comparison of 4 ultrasensitive prostate specific antigen assays for early detection of residual cancer after radical prostatectomy.
The Journal of urology 1994;152(5 Pt 1):1515-9.
1994: Thomas A Stamey; Zuxiong Chen; A Prestigiacomo
Serum prostate specific antigen binding alpha 1-antichymotrypsin: influence of cancer volume, location and therapeutic selection of resistant clones.
The Journal of urology 1994;152(5 Pt 1):1510-4.
1994: Thomas A Stamey; A F Prestigiacomo; Zuxiong Chen
Standardization of immunoassays for prostate specific antigen. A different view based on experimental observations.
Cancer 1994;74(6):1662-6.
1994: P D Lui; Martha Kennedy Terris; D J Haney; C E Constantinou; Thomas A Stamey
Prostate specific antigen as a predictor of an abnormal digital rectal examination.
British journal of urology 1994;74(3):337-40.
1994: Martha Kennedy Terris; Thomas A Stamey
Utilization of polyclonal serum prostate specific antigen levels in screening for prostate cancer: a comparison with corresponding monoclonal values.
British journal of urology 1994;73(1):61-4.
1993: H P Schmid; Fuad Freiha; John E McNeal; Thomas A Stamey
[Epidemiologic observations on prostate cancer based on tumor volumes].
Helvetica chirurgica acta 1993;60(3):355-8.
1993: Thomas A Stamey; M K Ferrari; H P Schmid
The value of serial prostate specific antigen determinations 5 years after radiotherapy: steeply increasing values characterize 80% of patients.
The Journal of urology 1993;150(6):1856-9.
1993: Martha Kennedy Terris; John E McNeal; Fuad Freiha; Thomas A Stamey
Efficacy of transrectal ultrasound-guided seminal vesicle biopsies in the detection of seminal vesicle invasion by prostate cancer.
The Journal of urology 1993;149(5):1035-9.
1993: A Villers; John E McNeal; Fuad Freiha; L Boccon-Gibod; Thomas A Stamey
Invasion of Denonvilliers' fascia in radical prostatectomy specimens.
The Journal of urology 1993;149(4):793-8.
1993: Thomas A Stamey; H C Graves; N Wehner; M Ferrari; Fuad Freiha
Early detection of residual prostate cancer after radical prostatectomy by an ultrasensitive assay for prostate specific antigen.
The Journal of urology 1993;149(4):787-92.
1993: J Iwakiri; K Granbois; N Wehner; H C Graves; Thomas A Stamey
An analysis of urinary prostate specific antigen before and after radical prostatectomy: evidence for secretion of prostate specific antigen by the periurethral glands.
The Journal of urology 1993;149(4):783-6.
1993: H P Schmid; John E McNeal; Thomas A Stamey
Observations on the doubling time of prostate cancer. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume.
Cancer 1993;71(6):2031-40.
1993: Thomas A Stamey; D D Dietrick; M M Issa
Large, organ confined, impalpable transition zone prostate cancer: association with metastatic levels of prostate specific antigen.
The Journal of urology 1993;149(3):510-5.
1993: Thomas A Stamey; Fuad Freiha; John E McNeal; E A Redwine; Alice S Whittemore; H P Schmid
Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer.
Cancer 1993;71(3 Suppl):933-8.
1993: Donna M Peehl; S T Wong; Thomas A Stamey
Vitamin A regulates proliferation and differentiation of human prostatic epithelial cells.
The Prostate 1993;23(1):69-78.
1992: A Villers; John E McNeal; Fuad Freiha; Thomas A Stamey
Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors.
Cancer 1992;70(9):2313-8.
1992: H P Schmid; John E McNeal; E A Redwine; Fuad Freiha; Thomas A Stamey
[Systematic morphometry of radical prostatectomy samples. A guideline for general practice].
Helvetica chirurgica acta 1992;59(3):471-6.
1992: Martha Kennedy Terris; John E McNeal; Thomas A Stamey
Detection of clinically significant prostate cancer by transrectal ultrasound-guided systematic biopsies.
The Journal of urology 1992;148(3):829-32.
1992: H C Graves; N Wehner; Thomas A Stamey
Ultrasensitive radioimmunoassay of prostate-specific antigen.
Clinical chemistry 1992;38(5):735-42.
1992: G F Daniels; John E McNeal; Thomas A Stamey
Predictive value of contralateral biopsies in unilaterally palpable prostate cancer.
The Journal of urology 1992;147(3 Pt 2):870-4.
1992: Martha Kennedy Terris; John E McNeal; Thomas A Stamey
Estimation of prostate cancer volume by transrectal ultrasound imaging.
The Journal of urology 1992;147(3 Pt 2):855-7.
1992: Martha Kennedy Terris; John E McNeal; Thomas A Stamey
Transrectal ultrasound imaging and ultrasound guided prostate biopsies in the detection of residual carcinoma in clinical stage A carcinoma of the prostate.
The Journal of urology 1992;147(3 Pt 2):864-9.
1992: G E Voges; John E McNeal; E A Redwine; Fuad Freiha; Thomas A Stamey
The predictive significance of substaging stage A prostate cancer (A1 versus A2) for volume and grade of total cancer in the prostate.
The Journal of urology 1992;147(3 Pt 2):858-63.
1992: G E Voges; John E McNeal; E A Redwine; Fuad Freiha; Thomas A Stamey
Morphologic analysis of surgical margins with positive findings in prostatectomy for adenocarcinoma of the prostate.
Cancer 1992;69(2):520-6.
1991: John E McNeal; J Alroy; A Villers; E A Redwine; Fuad Freiha; Thomas A Stamey
Mucinous differentiation in prostatic adenocarcinoma.
Human pathology 1991;22(10):979-88.
1991: John E McNeal; A Villers; E A Redwine; Fuad Freiha; Thomas A Stamey
Microcarcinoma in the prostate: its association with duct-acinar dysplasia.
Human pathology 1991;22(7):644-52.
1991: Martha Kennedy Terris; Fuad Freiha; John E McNeal; Thomas A Stamey
Efficacy of transrectal ultrasound for identification of clinically undetected prostate cancer.
The Journal of urology 1991;146(1):78-83; discussion 83-4.
1991: Martha Kennedy Terris; Thomas A Stamey
Determination of prostate volume by transrectal ultrasound.
The Journal of urology 1991;145(5):984-7.
1991: D M Peehl; S T Wong; Thomas A Stamey
Cytostatic effects of suramin on prostate cancer cells cultured from primary tumors.
The Journal of urology 1991;145(3):624-30.
1991: P Link; Fuad Freiha; Thomas A Stamey
Adjuvant radiation therapy in patients with detectable prostate specific antigen following radical prostatectomy.
The Journal of urology 1991;145(3):532-4.
1991: Fuad Freiha; A Villers; John E McNeal; Thomas A Stamey
Surgical margins at radical prostatectomy.
Progress in clinical and biological research 1991;370():301-3.
1991: A A Villers; John E McNeal; Fuad Freiha; Thomas A Stamey
Development of prostatic carcinoma. Morphometric and pathologic features of early stages.
Acta oncologica (Stockholm, Sweden) 1991;30(2):145-51.
1991: Donna M Peehl; S T Wong; Martha Kennedy Terris; Thomas A Stamey
Culture of prostatic epithelial cells from ultrasound-guided needle biopsies.
The Prostate 1991;19(2):141-7.
1990: H C Graves; N Wehner; Thomas A Stamey
Comparison of a polyclonal and monoclonal immunoassay for PSA: need for an international antigen standard.
The Journal of urology 1990;144(6):1516-22.
1990: H C Graves; M Kamarei; Thomas A Stamey
Identity of prostate specific antigen and the semen protein P30 purified by a rapid chromatography technique.
The Journal of urology 1990;144(6):1510-5.
1990: W L Lynes; S D Flynn; L D Shortliffe; Thomas A Stamey
The histology of interstitial cystitis.
The American journal of surgical pathology 1990;14(10):969-76.
1990: John E McNeal; A A Villers; E A Redwine; Fuad Freiha; Thomas A Stamey
Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate.
Cancer 1990;66(6):1225-33.
1990: H Price; John E McNeal; Thomas A Stamey
Evolving patterns of tissue composition in benign prostatic hyperplasia as a function of specimen size.
Human pathology 1990;21(6):578-85.
1990: A A Villers; John E McNeal; E A Redwine; Fuad Freiha; Thomas A Stamey
Pathogenesis and biological significance of seminal vesicle invasion in prostatic adenocarcinoma.
The Journal of urology 1990;143(6):1183-7.
1990: Thomas A Stamey; A A Villers; John E McNeal; P C Link; Fuad Freiha
Positive surgical margins at radical prostatectomy: importance of the apical dissection.
The Journal of urology 1990;143(6):1166-72; discussion 1172-3.
1990: A Villers; Martha Kennedy Terris; John E McNeal; Thomas A Stamey
Ultrasound anatomy of the prostate: the normal gland and anatomical variations.
The Journal of urology 1990;143(4):732-8.
1990: John E McNeal; A A Villers; E A Redwine; Fuad Freiha; Thomas A Stamey
Capsular penetration in prostate cancer. Significance for natural history and treatment.
The American journal of surgical pathology 1990;14(3):240-7.
1990: D M Peehl; S T Wong; John E McNeal; Thomas A Stamey
Analysis of somatic cell hybrids derived from normal human prostatic epithelial cells fused with HeLa cells.
The Prostate 1990;17(2):123-36.
1989: A Villers; John E McNeal; E A Redwine; Fuad Freiha; Thomas A Stamey
The role of perineural space invasion in the local spread of prostatic adenocarcinoma.
The Journal of urology 1989;142(3):763-8.
1989: J N Kabalin; K K Hodge; John E McNeal; Fuad Freiha; Thomas A Stamey
Identification of residual cancer in the prostate following radiation therapy: role of transrectal ultrasound guided biopsy and prostate specific antigen.
The Journal of urology 1989;142(2 Pt 1):326-31.
1989: K K Hodge; John E McNeal; Martha Kennedy Terris; Thomas A Stamey
Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate.
The Journal of urology 1989;142(1):71-4; discussion 74-5.
1989: K K Hodge; John E McNeal; Thomas A Stamey
Ultrasound guided transrectal core biopsies of the palpably abnormal prostate.
The Journal of urology 1989;142(1):66-70.
1989: J N Kabalin; John E McNeal; H M Price; Fuad Freiha; Thomas A Stamey
Unsuspected adenocarcinoma of the prostate in patients undergoing cystoprostatectomy for other causes: incidence, histology and morphometric observations.
The Journal of urology 1989;141(5):1091-4; discussion 1093-4.
1989: Thomas A Stamey; J N Kabalin; M Ferrari; N Yang
Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. IV. Anti-androgen treated patients.
The Journal of urology 1989;141(5):1088-90.
1989: Thomas A Stamey; J N Kabalin; M Ferrari
Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. III. Radiation treated patients.
The Journal of urology 1989;141(5):1084-7.
1989: Thomas A Stamey; J N Kabalin; John E McNeal; I M Johnstone; Fuad Freiha; E A Redwine; N Yang
Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients.
The Journal of urology 1989;141(5):1076-83.
1989: Thomas A Stamey; J N Kabalin
Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. I. Untreated patients.
The Journal of urology 1989;141(5):1070-5.
1989: J N Kabalin; D M Peehl; Thomas A Stamey
Clonal growth of human prostatic epithelial cells is stimulated by fibroblasts.
The Prostate 1989;14(3):251-63.
1988: John E McNeal; E A Redwine; Fuad Freiha; Thomas A Stamey
Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread.
The American journal of surgical pathology 1988;12(12):897-906.
1988: R G Harris; Christos E Constantinou; Thomas A Stamey
Extravesical subtrigonal injection of 50 per cent ethanol for detrusor instability.
The Journal of urology 1988;140(1):111-6.
1988: John E McNeal; J Alroy; I Leav; E A Redwine; Fuad Freiha; Thomas A Stamey
Immunohistochemical evidence for impaired cell differentiation in the premalignant phase of prostate carcinogenesis.
American journal of clinical pathology 1988;90(1):23-32.
1988: Thomas A Stamey; John E McNeal; Fuad Freiha; E Redwine
Morphometric and clinical studies on 68 consecutive radical prostatectomies.
The Journal of urology 1988;139(6):1235-41.
1988: John E McNeal; H M Price; E A Redwine; Fuad Freiha; Thomas A Stamey
Stage A versus stage B adenocarcinoma of the prostate: morphological comparison and biological significance.
The Journal of urology 1988;139(1):61-5.
1988: J H Reese; John E McNeal; E A Redwine; Thomas A Stamey; Fuad Freiha
Tissue type plasminogen activator as a marker for functional zones, within the human prostate gland.
The Prostate 1988;12(1):47-53.
1987: Thomas A Stamey; N Yang; A R Hay; John E McNeal; Fuad Freiha; E Redwine
Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.
The New England journal of medicine 1987;317(15):909-16.
1987: W L Lynes; S D Flynn; L D Shortliffe; M Lemmers; R Zipser; L J Roberts; Thomas A Stamey
Mast cell involvement in interstitial cystitis.
The Journal of urology 1987;138(4):746-52.
1986: J H Reese; John E McNeal; E A Redwine; I M Samloff; Thomas A Stamey
Differential distribution of pepsinogen II between the zones of the human prostate and the seminal vesicle.
The Journal of urology 1986;136(5):1148-52.
1986: John E McNeal; J H Reese; E A Redwine; Fuad Freiha; Thomas A Stamey
Cribriform adenocarcinoma of the prostate.
Cancer 1986;58(8):1714-9.
1986: John E McNeal; D G Bostwick; R A Kindrachuk; E A Redwine; Fuad Freiha; Thomas A Stamey
Patterns of progression in prostate cancer.
Lancet 1986;1(8472):60-3.